Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Apothecary Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$48M
Portfolio companies 5
Lead investments 1
Exits 4
Key employees Soon
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Biopharma
  • Medical
  • Health Care
  • Therapeutics
Summary

The main office of represented VC is situated in the Chicago. The fund was located in North America if to be more exact in United States.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Kythera Biopharmaceuticals, FibroGen, Cogentus Pharmaceuticals The fund has no exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Pharmaceutical, Medical. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

The usual cause for the fund is to invest in rounds with 9-10 partakers. Despite the Apothecary Capital, startups are often financed by Prospect Venture Partners, Versant Ventures, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Prospect Venture Partners, Versant Ventures, Frazier Healthcare Partners. In the next rounds fund is usually obtained by Versant Ventures, Temasek Holdings, Skyline Ventures.

The high activity for fund was in 2007. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Apothecary Capital works on 51 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2014.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Apothecary Capital:
Typical Co-investors
Apothecary Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Apothecary Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anzhuoxin Venture Capital China, Guangdong Province, Huizhou
Avlar BioVentures Cambridgeshire, Madingley, United Kingdom
Greenhouse Capital Partners California, Sausalito, United States
Manitou Ventures California, San Francisco, United States
MegaChips Japan, Osaka, Osaka Prefecture
Raised In Space Enterprises California, Santa Monica, United States
Rhiza Capital / Sunshine Coast Venture Partners -
Siemens Financial Services -
Zamagias Properties Inc. Pennsylvania, Pittsburgh, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Portola Pharmaceuticals

Biopharma
Biotechnology
Therapeutics
$60M01 Jul 2008 South San Francisco, California, United States

Kythera Biopharmaceuticals

Biopharma
Biotechnology
Health Care
$30M19 May 2008 California, United States

Cogentus Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$62M21 Dec 2007 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Apothecary Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 48M
Peak activity year 2007
Lead investments 1
Exits 4
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Portola Pharmaceuticals

Biopharma
Biotechnology
Therapeutics
$60M01 Jul 2008 South San Francisco, California, United States

Kythera Biopharmaceuticals

Biopharma
Biotechnology
Health Care
$30M19 May 2008 California, United States

Cogentus Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$62M21 Dec 2007 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: